Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Improved adherence through easier administration could address one of the core arguments that led to coverage removal
F.TomashevskyM.et al (2013)
The SUMMIT trial, involving 731 individuals with HFpEF and obesity followed for a median of 104 weeks, revealed a 38% decrease in the composite endpoint of cardiovascular mortality or heart-failure deterioration events (HR: 0.62, 95%CI: 0.41-0.95, P = 0.026), driven primarily by fewer worsening heart-failure events (8.0% vs
Built for Consistency, Not Quick Fixes
US$ 23.32
US$ 22.68
US$ 26.43
US$ 25.01
